SAS-B approvals Archives | Page 3 of 5 | Cannabiz

Scrutiny of SAS-B data for psychiatric conditions exposes prescribing ‘disconnect’

by Steve Jones June 7, 2023April 30, 2024

Patients are being prescribed medicinal cannabis for psychiatric conditions where evidence is lacking or unclear, in […]

SAS-B approvals rebound with second highest number of the year

by Steve Jones June 5, 2023April 30, 2024

Doctor Prescribing - Medical Cannabis - Cannabiz

SAS-B approvals fall to lowest level of the year

by Steve Jones May 5, 2023April 30, 2024

Queensland regains top spot as Australia’s cannabis capital

by Steve Jones April 4, 2023April 30, 2024

Queensland loses top spot for SAS-B approvals for first time in four years

by Steve Jones March 6, 2023April 30, 2024

January SAS-B approvals hit 9,000

by Steve Jones February 7, 2023April 29, 2024

SAS-B approvals dip in 2022 following TGA reforms, but patient numbers still climbing

by Martin Lane January 9, 2023April 29, 2024

THC Global

Approvals through SAS-B scheme the third highest this year

by Steve Jones December 8, 2022April 29, 2024

How to interpret the TGA’s Authorised Prescriber figures

by Rhys Cohen November 17, 2022April 29, 2024

TGA launches AP dashboard as SAS-B approvals remain steady

by Steve Jones November 2, 2022April 29, 2024